Analytical determination and pharmacokinetics of robenacoxib in the dog

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 1, 2009, Pages 41-48

  Jung, M ^a   Lees, P ^b   Seewald, W ^c   King, J N ^c  

^a Elanco Animal Health Research Centre   (Switzerland)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; ROBENACOXIB; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; FEMALE; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CROSS-OVER STUDIES; CYCLOOXYGENASE 2 INHIBITORS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTESTINAL ABSORPTION; MALE; METABOLIC CLEARANCE RATE; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY;

CANIS FAMILIARIS; FELIDAE;

EID: 58449083502     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.01035.x     Document Type: Article

References (12)

1. DEBA 1999) Data Evaluation in BioAnalytics; Release 4.1XP. Novartis Pharma, Basel, Switzerland.
2. Esser, R., Berry, C., Zhengming, D., Dawson, J., Fox, A., Fujimoto, R.A., Haston, W., Kimble, E.F., Koehler, J., Peppard, J., Quadros, E., Quintavalla, J., Toscano, K., Urban, L., Van Duzer, J., Zhang, X., Zhou, S. Marshall, P.J. (2005) Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. British Journal of Pharmacology, 144, 538 550.
3. FDA 2001) US Department of Health and Human Service, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) and Center for Veterinary Medicine (VDM), Guidance for Industry, Bioanalytical Method Validation, May 2001.
4. Giraudel, J.M., King, J.N., Jeunesse, E.C., Lees, P. Toutain, P.L. (2009) Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib. Journal of Veterinary Pharmacology and Therapeutics, 32, 18 30.
5. King, J.N., Dawson, J., Esser, R.E., Fujimoto, R., Kimble, E.F., Maniara, W., Marshall, P.J., O'Byrne, L.O., Quadros, E., Toutain, P.L. Lees, P. (2009) Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2. Journal of Veterinary Pharmacology and Therapeutics, 32, 1 17.
6. Lees, P., Landoni, M.F., Giraudel, J. Toutain, P.L. (2004) Pharmacodynamics and pharmacokinetics of non-steroidal anti-inflammatory drugs in species of veterinary interest. Journal of Veterinary Pharmacology and Therapeutics, 27, 479 490.
7. Millipore (2002 Centrifree and MPS Micropartition devices, the manufacturer's Operating Manual obtained with the package, Millipore 2002, Bedford, MA 01730, USA.
8. Paulson, S.K., Vaughn, M.B., Jessen, S.M., Lawal, Y., Gresk, C.J., Yan, B., Maziasz, T.J., Cook, C.S. Karim, A. (2001) Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. Journal of Pharmacology and Experimental Therapeutics, 297, 638 645.
9. Rordorf, C.M., Choi, L., Marshall, P. Mangold, J.B. (2005) Clinical pharmacology of lumiracoxib. A selective cyclo-oxygenase-2 inhibitor. Clinical Pharmacokinetics, 44, 1247 1266.
10. Toutain, P.L. Bousquet-Melou, A. (2002) Free drug fraction vs. free drug concentration: a matter of frequent confusion. Journal of Veterinary Pharmacology and Therapeutics, 25, 460 463.
11. Toutain, P.L. Bousquet-Melou, A. (2004a) Plasma clearance. Journal of Veterinary Pharmacology and Therapeutics, 27, 415 425.
12. Toutain, P.L. Bousquet-Melou, A. (2004b) Bioavailability and its assessment. Journal of Veterinary Pharmacology and Therapeutics, 27, 455 466.